Valuation: DexCom, Inc.

Market Cap 34.85B 29.85B 27.93B 25.57B 47.98B 3,334B 48.61B 330B 129B 1,675B 131B 128B 5,540B P/E 2026 *
37x
P/E 2027 * 31.1x
Enterprise Value 34.08B 29.2B 27.32B 25.01B 46.93B 3,261B 47.55B 323B 126B 1,638B 128B 125B 5,419B EV / Sales 2026 *
6.52x
EV / Sales 2027 * 5.83x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+2.35%
1 week+2.89%
Current month+10.65%
1 month+23.53%
3 months+28.43%
6 months+26.35%
Current year+39.13%
1 week 88.14
Extreme 88.145
92.56
1 month 69.79
Extreme 69.79
92.56
Current year 56.72
Extreme 56.72
92.56
1 year 54.11
Extreme 54.11
92.56
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
14/8/26 Sell

General Counsel

-1,700 0.0005%
12/8/26 Don

Director

-1,075 0.0003%
12/8/26 Sell

Director

-1,012 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.35%+2.89%+14.54%-11.79% 34.85B
+2.19%+4.84%-11.64%+12.29% 202B
+1.14%+2.28%+2.47%+14.39% 119B
+1.06%+1.34%+4.88%+75.73% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-2.35%-30.34% 52.3B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+45.52%-10.08% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
+0.93%+1.99%-3.87%+6.81% 23.2B
Average +1.33%+0.24%+8.02%+15.56% 62.35B
Weighted average by Cap. +1.51%+1.83%+1.74%+17.44%

Financials

2026 *2027 *
Net sales 5.23B 4.48B 4.19B 3.84B 7.2B 500B 7.3B 49.53B 19.31B 251B 19.64B 19.21B 831B 5.8B 4.97B 4.65B 4.26B 7.99B 555B 8.09B 54.92B 21.42B 279B 21.78B 21.3B 922B
Net income 974M 835M 781M 715M 1.34B 93.23B 1.36B 9.23B 3.6B 46.83B 3.66B 3.58B 155B 1.15B 984M 921M 843M 1.58B 110B 1.6B 10.88B 4.24B 55.22B 4.31B 4.22B 183B
Net Debt -761M -652M -610M -558M -1.05B -72.83B -1.06B -7.21B -2.81B -36.58B -2.86B -2.8B -121B -1.06B -909M -851M -779M -1.46B -102B -1.48B -10.05B -3.92B -51.02B -3.99B -3.9B -169B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
21/08/26 USD 92.34 +2.35% 3,481,760
20/08/26 USD 90.22 +0.38% 5,164,593
19/08/26 USD 89.88 +0.31% 8,668,160
18/08/26 USD 89.60 +0.95% 3,363,035
17/08/26 USD 88.76 -1.10% 4,048,868
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
92.34USD
Average target price
94.12USD
Spread / Average Target
+1.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock